Wells Fargo initiated coverage of Henry Schein (HSIC) with an Equal Weight rating and $80 price target The stock’s risk/reward is balanced at ...

BofA analyst Allen Lutz double upgraded Henry Schein (HSIC) to Buy from Underperform with a price target of $84, up from $69. The firm believes ...

This was the stock's fourth consecutive day of losses.

Analysts at Barrington Research cut their Q1 2025 earnings estimates for shares of Henry Schein in a research report issued ...

Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq: HSIC), is paying tribute to women athletic ...

This belief drove our collaboration with Henry Schein One, a division of Henry Schein, a leader in dental software solutions, to launch a dynamic new website designed to set the standard for ...

Private equity firm KKR has taken a large stake in Henry Schein and reached a deal to add members to the company's board, the ...

NEW YORK, Jan 22 (Reuters) - Activist investor Ananym Capital Management plans to nominate as many as half a dozen directors to the board at Henry Schein (HSIC.O), opens new tab, arguing the ...

Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Henry Schein HSIC in the last three months. The table below offers a condensed view of their ...

NEW YORK (Reuters) - Activist investor Ananym Capital Management plans to nominate as many as half a dozen directors to the board at Henry Schein, arguing the dental and medical distributor needs ...

KKR has made an investment in Henry Schein Inc, a Melville, New York-based provider of healthcare solutions to office-based dental and medical practitioners. Stanley Bergman serves as CEO of Henry ...